Torrey Craig to CHI

Jul 15, 20232023-24free agent signingplayer page →transaction →

Listed top needs: rebounding, shooting, passing.

Strongest prior functions: rim protection, rebounding, shooting.

Stable front-end label for the underlying evidence state; inspect the supporting relation for the measured fields and evidence boundary.

Matched needs: rebounding, shooting. Match ratio 67%.

The incoming player's strongest observed functions matched one or more of the receiving team's leading pre-move needs.

Post-move strongest functions: shooting, rebounding, rim protection. Realized overlap 100%.

All of the player's strongest prior functions appeared in his receiving-team profile after the acquisition.

No outgoing assets recorded

Stable front-end label for the underlying evidence state; inspect the supporting relation for the measured fields and evidence boundary.

Selected player charge $2.53M — 1.9% of the cap

Lead executive: Artūras Karnišovas. regime page →

The decision date falls inside one resolved basketball-authority regime for this team.

{"team":"CHI","build_id":"authority_regime_portfolio_lineup_context_portability_resilience_v1_20260823","plain_label":"Abstain No Retained Provider Baseline","recorded_at":"2026-08-23T21:07:03.685926+00:00","available_at":"2026-08-23T21:07:03.685925+00:00","franchise_id":34,"decision_date":"2023-07-

{"team":"CHI","build_id":"authority_regime_portfolio_lineup_context_portability_resilience_v1_20260823","plain_label":"Abstain No Retained Provider Baseline","recorded_at":"2026-08-23T21:07:03.685974+00:00","available_at":"2026-08-23T21:07:03.685972+00:00","franchise_id":34,"decision_date":"2023-07-

{"team":"CHI","build_id":"authority_regime_portfolio_lineup_context_portability_resilience_v1_20260823","plain_label":"Direct Delivery Observed In Shared And Alternating Provider Contexts","recorded_at":"2026-08-23T21:07:03.686023+00:00","available_at":"2026-08-23T21:07:03.686021+00:00","franchise_i

{"team":"CHI","build_id":"authority_regime_portfolio_lineup_function_interaction_v1_20260822","plain_label":"Abstain No Retained Provider Baseline","recorded_at":"2026-08-23T05:21:15.726073+00:00","available_at":"2026-08-23T05:21:37.191554+00:00","franchise_id":34,"decision_date":"2023-07-15","funct

{"team":"CHI","build_id":"authority_regime_portfolio_lineup_function_interaction_v1_20260822","plain_label":"Abstain No Retained Provider Baseline","recorded_at":"2026-08-23T05:21:15.726073+00:00","available_at":"2026-08-23T05:21:37.191605+00:00","franchise_id":34,"decision_date":"2023-07-15","funct

{"team":"CHI","build_id":"authority_regime_portfolio_lineup_function_interaction_v1_20260822","plain_label":"Shared and separate lineup delivery","recorded_at":"2026-08-23T05:21:15.726073+00:00","available_at":"2026-08-23T05:21:37.191624+00:00","franchise_id":34,"decision_date":"2023-07-15","functio

{"team":"CHI","build_id":"authority_regime_portfolio_function_workload_transfer_v1_20260822","plain_label":"No Retained Provider Baseline","recorded_at":"2026-08-23T02:46:37.43008+00:00","available_at":"2026-08-23T02:46:37.43008+00:00","franchise_id":34,"decision_date":"2023-07-15","function_code":"